Brandi G.; Relli V.; Deserti M.; Palloni A.; Indio V.; Astolfi A.; Serravalle S.; Mattiaccio A.; Vasuri F.; Malvi D.; Deiana C.; Pantaleo M.A.; Cescon M.; Rizzo A.; Katoh M.; Tavolari S., Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies, «SCIENTIFIC REPORTS», 2024, 14, Article number: 3136, pp. 1 - 10 [articolo]Open Access
Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M., FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions., «NATURE REVIEWS. CLINICAL ONCOLOGY», 2024, 21, pp. 312 - 329 [articolo]
Brandi G.; Calabrese C.; Tavolari S.; Bridonneau C.; Raibaud P.; Liguori G.; Thomas M.; Di Battista M.; Gaboriau-Routhiau V.; Langella P., Intestinal Microbiota Increases Cell Proliferation of Colonic Mucosa in Human-Flora-Associated (HFA) Mice, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2024, 25, pp. 1 - 11 [articolo]
Brandi G.; Deiana C.; Galvani L.; Palloni A.; Ricci A.D.; Rizzo A.; Tavolari S., Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue, «FRONTIERS IN ONCOLOGY», 2023, 13, Article number: 1137510, pp. 1 - 10 [articolo]Open Access
Vasuri, Francesco; Deserti, Marzia; Corradini, Angelo G; Tavolari, Simona; Relli, Valeria; Palloni, Andrea; Frega, Giorgio; Curti, Stefania; Mattioli, Stefano; Cescon, Matteo; D'Errico, Antonia; Brandi, Giovanni, Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study, «SCIENTIFIC REPORTS», 2023, 13, Article number: 2580, pp. 1 - 7 [articolo]Open Access
Brandi G.; Tovoli F.; Tavolari S., Have We Found the “Holy Grail” That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?, «GASTROENTEROLOGY», 2023, 164, pp. 15 - 18 [articolo]
Deiana C.; Fabbri F.; Tavolari S.; Palloni A.; Brandi G., Improvements in Systemic Therapies for Advanced Malignant Mesothelioma, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, pp. 10415 - 10436 [articolo]
Tavolari S.; Brandi G., Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review, «CELLS», 2023, 12, Article number: 1216, pp. 1 - 14 [articolo]Open Access
Brandi, Giovanni; Straif, Kurt; Mandrioli, Daniele; Curti, Stefania; Mattioli, Stefano; Tavolari, Simona, Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link, «ANNALS OF GLOBAL HEALTH», 2022, 88, Article number: 41, pp. 1 - 6 [articolo]Open Access
Di Federico A.; Mosca M.; Pagani R.; Carloni R.; Frega G.; De Giglio A.; Rizzo A.; Ricci D.; Tavolari S.; Di Marco M.; Palloni A.; Brandi G., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429, pp. 1 - 14 [articolo]Open Access
Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi., Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes, «CANCERS», 2022, 14, Article number: 2429, pp. 1 - 14 [articolo]Open Access
Rizzo, A.; Frega, G.; Palloni, A.; Piemontese, A.; Di Federico, A.; Ricci, A.; Carloni, R.; Fabbri, F.; Novelli, M.; Tavolari, S.; Di Marco, M.; Ravaioli, M.; Brandi, G., Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience, «ANNALS OF ONCOLOGY», 2021, 32, Article number: P-69, pp. S120 - S120 [articolo]Open Access
Di Federico A.; Rizzo A.; Ricci A.D.; Frega G.; Palloni A.; Tavolari S.; Brandi G., Nivolumab: an investigational agent for the treatment of biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 325 - 332 [articolo]
Rizzo A.; Frega G.; Ricci A.D.; Palloni A.; Abbati F.; de Lorenzo S.; Deserti M.; Tavolari S.; Brandi G., Anti-EGFR monoclonal antibodies in advanced biliary tract cancer: A systematic review and meta-analysis, «IN VIVO», 2020, 34, pp. 479 - 488 [articolo]
Brandi G.; Tavolari S., Asbestos and Intrahepatic Cholangiocarcinoma, «CELLS», 2020, 9, Article number: 421, pp. 1 - 15 [articolo]Open Access